AKEBIA THERAPEUTICS INC (AKBA) Stock Price & Overview
NASDAQ:AKBA • US00972D1054
Current stock price
The current stock price of AKBA is 1.43 USD. Today AKBA is down by 0%. In the past month the price increased by 2.88%. In the past year, price decreased by -39.92%.
AKBA Key Statistics
- Market Cap
- 383.068M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -0.02
- Dividend Yield
- N/A
AKBA Stock Performance
AKBA Stock Chart
AKBA Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to AKBA. When comparing the yearly performance of all stocks, AKBA is a bad performer in the overall market: 84.57% of all stocks are doing better.
AKBA Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to AKBA. While AKBA is still in line with the averages on profitability rating, there are concerns on its financial health.
AKBA Earnings
On February 26, 2026 AKBA reported an EPS of -0.05 and a revenue of 57.62M. The company missed EPS expectations (-96.08% surprise) and beat revenue expectations (22.56% surprise).
AKBA Forecast & Estimates
11 analysts have analysed AKBA and the average price target is 4.49 USD. This implies a price increase of 213.85% is expected in the next year compared to the current price of 1.43.
For the next year, analysts expect an EPS growth of -359% and a revenue growth 0.95% for AKBA
AKBA Groups
Sector & Classification
AKBA Financial Highlights
Over the last trailing twelve months AKBA reported a non-GAAP Earnings per Share(EPS) of -0.02. The EPS increased by 93.94% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -1.42% | ||
| ROE | -16.39% | ||
| Debt/Equity | 5.4 |
AKBA Ownership
AKBA Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 13.4 | 351.47B | ||
| AMGN | AMGEN INC | 15.09 | 185.95B | ||
| GILD | GILEAD SCIENCES INC | 14.75 | 161.855B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 22.09 | 109.449B | ||
| REGN | REGENERON PHARMACEUTICALS | 16.03 | 79.456B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 44.76 | 40.768B | ||
| INSM | INSMED INC | N/A | 29.176B | ||
| NTRA | NATERA INC | N/A | 28.878B | ||
| BIIB | BIOGEN INC | 11.44 | 27.06B | ||
| RVMD | REVOLUTION MEDICINES INC | N/A | 26.812B | ||
| UTHR | UNITED THERAPEUTICS CORP | 19.41 | 24.859B | ||
| MRNA | MODERNA INC | N/A | 20.119B | ||
| INCY | INCYTE CORP | 12.23 | 18.836B |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About AKBA
Company Profile
The company is headquartered in Cambridge, Massachusetts and currently employs 194 full-time employees. The company went IPO on 2014-03-20.
Company Info
IPO: 2014-03-20
AKEBIA THERAPEUTICS INC
245 First Street
Cambridge MASSACHUSETTS 02142 US
CEO: John P. Butler
Employees: 194
Phone: 13026587581
AKEBIA THERAPEUTICS INC / AKBA FAQ
What does AKBA do?
The company is headquartered in Cambridge, Massachusetts and currently employs 194 full-time employees. The company went IPO on 2014-03-20.
What is the current price of AKBA stock?
The current stock price of AKBA is 1.43 USD.
What is the dividend status of AKEBIA THERAPEUTICS INC?
AKBA does not pay a dividend.
What is the ChartMill technical and fundamental rating of AKBA stock?
AKBA has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
How is the market expecting AKBA stock to perform?
11 analysts have analysed AKBA and the average price target is 4.49 USD. This implies a price increase of 213.85% is expected in the next year compared to the current price of 1.43.
Should I buy AKBA stock?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on AKBA.